CAR T-Cell Therapy

>

Latest News

Innovative mRNA CAR Therapy MT-303 Under Study for Liver Cancer
Innovative mRNA CAR Therapy MT-303 Under Study for Liver Cancer

December 20th 2024

MT-303, a novel GPC3-targeting mRNA/lipid nanoparticle chimeric antigen receptor therapy, enhances cytokine-driven immune response and tumor cytotoxicity.

Biomarkers and Treatment Strategies in CAR T-Cell Therapy for R/R Multiple Myeloma
Biomarkers and Treatment Strategies in CAR T-Cell Therapy for R/R Multiple Myeloma

December 14th 2024

Real-World Data Supports Efficacy and Safety of Liso-cel in Second-Line LBCL Treatment
Real-World Data Supports Efficacy and Safety of Liso-cel in Second-Line LBCL Treatment

December 13th 2024

Outpatient Lymphodepletion Before Brexucabtagene Autoleucel Shows Similar Outcomes
Outpatient Lymphodepletion Before Brexucabtagene Autoleucel Shows Similar Outcomes

December 13th 2024

Brexu-Cel Achieves High Response Rates in BTK-Inhibitor-Naive MCL
Brexu-Cel Achieves High Response Rates in BTK-Inhibitor-Naive MCL

December 11th 2024

Video Series
Video Interviews

More News